All News - ALZFORUM
WEBSep 27, 2024 · TYPE OF NEWS. Research News (4487) Conference Coverage (1400) Community News (276) Interviews (33) Book Reviews (8) DISEASE. Alzheimer's Disease (3317) Amyotrophic Lateral Sclerosis (540) Parkinson's Disease (475) Frontotemporal Dementia (430) Triplet Repeat Diseases (152) Dementia with Lewy Bodies (115) Progressive Supranuclear Palsy (94 ...
ALZFORUM | NETWORKING FOR A CURE
WEB3 days ago · Dena Dubal on X-Chromosome-Wide Association Data Spot Alzheimer’s Loci 26 Sep 2024 Monica Rosselli on A Country Doctor, But Oh So Much More: Francisco Lopera, 73 20 Sep 2024 Lary Walker on Human Cell Models Reveal Two Sides to α-Synuclein Inclusions 20 Sep 2024
2023—A Bumper Year for the Treatment and Science of Alzheimer's
WEBDec 26, 2023 · Throughout 2023, scientists studied the entire crop of anti-amyloid antibodies to learn more about when to treat (before amyloid “bothers” tau) and how much plaque to remove (all of it). A tantalizing foreshadowing of potential Alzheimer's prevention with anti-amyloid therapy came from the Dominantly Inherited Alzheimer's Network (DIAN).
Aducanumab Approved to Treat Alzheimer’s Disease
WEBJun 8, 2021 · On the other hand, patient advocacy groups lobbied for aducanumab. The Alzheimer’s Association launched its “More Time” social media campaign in May, arguing that even a modest slowing of clinical decline would be meaningful to patients and their families. Us Against Alzheimer’s urged its members to write to …
Do Two APOE4 Alleles Always Mean Alzheimer's? - ALZFORUM
WEBMay 10, 2024 · They used these numbers to counsel participants in the Alzheimer’s Prevention Initiative’s Generation trial, which specifically enrolled APOE4 carriers (Sep 2016 news). They also noted that at the time of enrollment, a third of APOE4 homozygotes, between the ages of 60 to 75, did not meet the criteria for amyloid positivity.
A New Era of Alzheimer’s Treatment - ALZFORUM
WEBOther stakeholders hailed the decision, as well. In addition to positive reaction from advocacy groups such as the Alzheimer’s Association and Us Against Alzheimer’s, the Global Alzheimer’s Platform commended the FDA for its stance, and the National Institutes of Health called the approval a milestone achievement. “The hope is greater ...
FDA Will Regulate Diagnostic Tests. Yes, Those for Alzheimer’s, Too.
WEBMay 29, 2024 · How Do Alzheimer’s Tests Stack Up? If the ruling stands, how will it affect tests for Alzheimer’s disease? The answer will likely vary by company. For example, Fujirebio received FDA approval for its automated Aβ42/40 CSF assay, and Roche for its automated Aβ42/p-tau181 and Aβ42/t-tau CSF tests (May 2022 news; Dec …
Revised Again: Alzheimer's Diagnostic Criteria Get Another …
WEBSep 16, 2022 · The system distinguished clinical stages from 1 to 6, with 1 being biomarker change only, 2, subtle cognitive change, 3, mild cognitive impairment, and 4-6, mild, moderate, and severe dementia (Apr 2018 news; Nov 2018 conference news). The criteria were intended to be a work in progress, and to incorporate new data once it was available.
New Alzheimer’s Diagnostic Criteria Remain ‘Research Only’
WEBNov 28, 2023 · The latest effort to rewrite the diagnostic criteria for Alzheimer’s disease has stirred more than a little controversy. While the proposed revisions have garnered praise from researchers for more accurately reflecting the underlying biology of the disease, they also have sparked criticism for advancing toward clinical use what were ...
Massive GWAS Meta-Analysis Digs Up Trove of Alzheimer’s Genes
WEBFeb 25, 2021 · Geneticists at the International Genomics of Alzheimer’s Project analyzed more than 35,000 cases to find five new loci (Mar 2019 news). A separate effort went broader by including UK Biobank samples from people with family histories of dementia, known as genome-wide association-by-proxy (GWAX); it uncovered nine new genes among almost 72,000 ...